Toxoplasma gondii antigens: Recovery analysis of tachyzoites cultivated in Vero cell maintained in serum free medium

Experimental Parasitology

Volumn 130, Issue 4, 2012, Pages 463-469

  da Costa Silva, Thaís Alves ^a   da Silva Meira, Cristina ^a   Frazzatti Gallina, Neuza ^b   Pereira Chioccola, Vera Lucia ^a  

^a INSTITUTO ADOLFO LUTZ   (Brazil)

^b INSTITUTO BUTANTAN   (Brazil)

Author keywords

Antigens; Serum free medium; Tachyzoites; Toxoplasma gondii; Vero cells

Indexed keywords

PARASITE ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRODUCTION; ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; EXPERIMENTAL INFECTION; FEMALE; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; MONOLAYER CULTURE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PROTOZOAL INFECTION; TACHYZOITE; TOXOPLASMA GONDII; VERO CELL;

ANIMALS; ANTIGENS, PROTOZOAN; BASE SEQUENCE; CERCOPITHECUS AETHIOPS; CULTURE MEDIA, SERUM-FREE; DNA, PROTOZOAN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNE SERA; MICE; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; PROTOZOAN PROTEINS; SEQUENCE ALIGNMENT; SERIAL PASSAGE; SPECIFIC PATHOGEN-FREE ORGANISMS; TOXOPLASMA; VERO CELLS;

ANIMALIA; BOVINAE; MUS; PROTOZOA; TOXOPLASMA GONDII;

EID: 84859101266     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2012.01.005     Document Type: Article

References (50)

1. Ahn M.H., Hyun K.H., Kang J.O., Min D.Y. Partially purified Toxoplasma gondii antigens by immunoaffinity chromatography. Korean Journal of Parasitology 1997, 35:251-258.
2. Ashburn D., Evans R., Chatterton J.M.W., Joss A.W.L., Ho-Yen D.O. Toxoplasma dye test using cell culture derived tachyzoites. Journal of Clinical Pathology 2000, 53:630-633.
3. Bojar I., Szymańska J. Environmental exposure of pregnant women to infection with Toxoplasma gondii - state of the art. Annals of Agricultural and Environmental Medicine 2010, 17:209-214.
4. Buddhirongawatr R., Tungsudjai S., Chaichoune K., Sangloung C., Tantawiwattananon N., Phonaknguen R., Sukthana Y. Detection of Toxoplasma gondii in captive wild felids. The Southeast Asian Journal of Tropical Medicine and Public Health 2006, 3:15-17.
5. Bunetel L., Guerin J., Andre P., Roberts R., Deunff J. Calibration of an in vitro assay system using a non-adherent cell line to evaluate the effect of a drug on Toxoplasma gondii. International Journal for Parasitology 1995, 25:699-704.
6. Calico I., Caballero E., Martinez O., Arcalis Arce L., Llopart L., Ocana I., Juste C. Isolation of Toxoplasma gondii from immunocompromised patients using tissue culture. Infection 1991, 19:340-342.
7. Chatterton J.M., Evans R., Ashburn D., Joss A.W., Ho-Yen D.O. Toxoplasma gondii in vitro culture for experimentation. Journal of Microbiological Methods 2002, 51:331-335.
8. Colombo F.A., Vidal J.E., Penalva de Oliveira A.C., Hernández A.V., Bonasser-Filho F., Nogueira R.S., Focaccia R., Pereira-Chioccola V.L. Diagnosis of cerebral toxoplasmosis in AIDS patients in Brazil: importance of molecular and immunological methods using peripheral blood samples. Journal of Clinical Microbiology 2005, 43:5044-5047.
9. Costa-Silva T.A., Meira C.S., Ferreira I.M., Hiramoto R.M., Pereira-Chioccola V.L. Evaluation of immunization with tachyzoite excreted-secreted proteins in a novel susceptible mouse model (A/Sn) for Toxoplasma gondii. Experimental Parasitology 2008, 120:227-234.
10. Deĝirmenci A., Döşkaya M., Caner A., Ciçek C., Korkmaz M., Gürüz Y., Uner A. Toxoplasma gondii RH Ankara: production of evolving tachyzoites using a novel cell culture method. Experimental Parasitology 2011, 128:1-8.
11. Derouin F., Mazeron M.C., Garin Y.J.F. Comparative study of tissue culture and mouse inoculation methods for demonstration of Toxoplasma gondii. Journal of Clinical Microbiology 1987, 25:1597-1600.
12. Diab M.R., El-Bahy M.M. Toxoplasma gondii: virulence of tachyzoites in serum free media at different temperatures. Experimental Parasitology 2008, 118:75-79.
13. Domzig W., Seguela J.-P., Binz H. A method to obtain large quantities of Toxoplasma gondii tachyzoites with extreme purity. The Journal of Parasitology 1993, 79:613-615.
14. Dubey J.P. Advances in the life cycle of Toxoplasma gondii. International Journal for Parasitology 1998, 7:1019-1024.
15. Elmore S.A., Jones J.L., Conrad P.A., Patton S., Lindsay D.S., Dubey J.P. Toxoplasma gondii: epidemiology, feline clinical aspects, and prevention. Trends in Parasitology 2010, 26:190-196.
16. Evans R., Chatterton J.M., Ashburn D., Joss A.W., Ho-Yen D.O. Cell-culture system for continuous production of Toxoplasma gondii tachyzoites. European Journal of Clinical Microbiology & Infectious Diseases 1999, 18:879-884.
17. Ferreira I.M., Vidal J.E., Costa-Silva T.A., Meira C.S., Hiramoto R.M., Penalva de Oliveira A.C., Pereira-Chioccola V.L. Toxoplasma gondii: genotyping of strains from Brazilian AIDS patients with cerebral toxoplasmosis by multilocus PCR-RFLP markers. Experimental Parasitology 2008, 118:221-227.
18. Ferreira-da-Silva M.F., Rodrigues R.M., de Andrade E.F., de Carvalho L., Gross U., Lüder C.G., Barbosa H.S. Spontaneous stage differentiation of mouse-virulent Toxoplasma gondii RH parasites in skeletal muscle cells: an ultrastructural evaluation. Memorias do Instituto Oswaldo Cruz 2009, 104:196-200.
19. Fichera M.E., Bhopale M.K., Roos D.S. In vitro assays elucidate peculiar kinetics of clindamycin action against Toxoplasma gondii. Antimicrobial Agents and Chemotherapy 1995, 39:1530-1537.
20. Fichera M.E., Roos D.S. A plastid organelle as a drug target in apicomplexan parasites. Nature 1997, 390:407-409.
21. Fishbein D.B., Yenne K.M., Dreesen D.W., Teplis C.F., Mehta N., Briggs D.J. Risk factors for systemic hypersensitivity reactions after booster vaccinations with human diploid cell rabies vaccine: a nationwide prospective study. Vaccine 1993, 14:1390-1394.
22. Frazatti-Gallina N.M., Mourão-Fuches R.M., Paoli R.L., Silva M.L., Miyaki C., Valentini E.J., Raw I., Higashi H.G. Vero-cell rabies vaccine produced using serum-free medium. Vaccine 2004, 23:511-517.
23. Froud S.J. The development, benefits and disadvantages of serum-free media. Developments in Biological Standardization 1999, 99:157-166.
24. Furesz J., Fanok A., Contreras G., Becker B. Tumorigenicity testing of various cell line substrates for production of biological. Developments in Biological Standardization 1989, 70:233-243.
25. Garcia J.L., Gennari S.M., Navarro I.T., Machado R.Z., Sinhorini I.L., Freire R.L., Marana E.R., Tsutsui V., Contente A.P., Begale L.P. Partial protection against tissue cyst formation in pigs vaccinated with crude rhoptery proteins of Toxoplasma gondii. Veterinary Parasitology 2005, 129:209-217.
26. Gail M., Gross U., Bohne W. Transferrin receptor induction in Toxoplasma gondii-infected HFF is associated with increased iron-responsive protein 1 activity and is mediated by secreted factors. Parasitology Research 2004, 94(3):233-239.
27. Harmer C., Hassl A., Kreinecker S., Aspöck H. Toxoplasma gondii in vitro cultivation: economic and efficient mass production. Journal of Microbiological Methods 1996, 27:225-228.
28. Hass A., Aspock H. A rapid and simple method of purification of Toxoplasma gondii trophozoites originating from tissue culture for use in the indirect immunofluorescent antibody test. Zentralblatt fur Bakteriologie 1990, 272:509-513.
29. Howe D.K., Honoré S., Derouin F., Sibley L.D. Determination of genotypes of Toxoplasma gondii strains isolated from patients with toxoplasmosis. Journal of Clinical Microbiology 1997, 35:1411-1414.
30. Hughes H.P., Hudson L., Fleck D.G. In vitro culture of Toxoplasma gondii in primary and established cell lines. International Journal of Parasitology 1986, 4:317-322.
31. Khan A., Fux B., Su C., Dubey J.P., Darde M.L., Ajioka J.W., Rosenthal B.M.L., Sibley D. Recent transcontinental sweep of Toxoplasma gondii driven by a single monomorphic chromosome. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:14872-14877.
32. Lee E.J., Heo Y.M., Choi J.H., Song H.O., Ryu J.S., Ahn M.H. Suppressed production of pro-inflammatory cytokines by LPS-activated macrophages after treatment with Toxoplasma gondii lysate. Korean Journal of Parasitology 2008, 46:145-151.
33. Lynch M.I., Malagueño E., Lynch L.F., Ferreira S., Stheling R., Oréfice F. Anti-Toxoplasma gondii secretory IgA in tears of patients with ocular toxoplasmosis: immunodiagnostic validation by ELISA. Memorias do Instituto Oswaldo Cruz 2009, 104:818-822.
34. Macre Mde.S., Pires M., Meireles L.R., Angel S.O., Andrade H.F. Serology using rROP2 antigen in the diagnostic of toxoplasmosis in pregnant women. Revista do Instituto de Medicina Tropical de São Paulo 2009, 51:283-288.
35. Mavin S., Joss A.W., Ball J., Ho-Yen D.O. Do Toxoplasma gondii RH strain tachyzoites evolve during continuous passage?. Journal of Clinical Pathology 2004, 57:609-611.
36. Meira C.S., Costa-Silva T.A., Vidal J.E., Ferreira I.M., Hiramoto R.M., Pereira-Chioccola V.L. Use of the serum reactivity against Toxoplasma gondii excreted-secreted antigens in cerebral toxoplasmosis diagnosis in human immunodeficiency virus-infected patients. Journal Medical of Microbiology 2008, 57:845-850.
37. Molestina R.E., El-Guendy N., Sinai A.P. Infection with Toxoplasma gondii results in dysregulation of the host cell cycle. Cell Microbiology 2008, 10:1153-1165.
38. Monath T.P., Fowler E., Johnson C.T., Balser J., Morin M.J., Sisti M., Trent D.W. An inactivated cell-culture vaccine against yellow fever. New England Journal of Medicine 2011, 364:1326-1333.
39. Pereira-Chioccola V.L., Vidal J.E., Su C. Toxoplasma gondii infection and cerebral toxoplasmosis in HIV-infected patients. Future Microbiology 2009, 4:1363-1379.
40. Roos D.S., Donald R.G.K., Mourrissette N.S., Moulton A.L.C. Molecular tools for genetic dissection of the protozoan parasite Toxoplasma gondii. Methods in Cell Biology 1994, 45:27-63.
41. Saadatnia G., Haj Ghani H., Khoo B.Y., Maimunah A., Rahmah N. Optimization of Toxoplasma gondii cultivation in VERO cell line. Tropical Biomedicine 2010, 27:125-130.
42. Sabin A.B. Toxoplasmic encephalitis in children. Journal of the American Medical Association 1941, 116:801-807.
43. Sibley L.D., Boothroyd J.C. Virulent strains of Toxoplasma gondii comprise a single clonal lineage. Nature 1992, 359:82-85.
44. Su C., Zhang X., Dubey J.P. Genotyping of Toxoplasma gondii by multilocus PCR-RFLP markers: a high resolution and simple method for identification of parasites. International Journal for Parasitology 2006, 36:841-848.
45. Tenter A.M., Heckeroth A.R., Weiss L.M. Toxoplasma gondii: from animals to humans. International Journal for Parasitology 2000, 30:1217-1258.
46. Toriniwa H., Komiya T. Comparison of viral glycosylation using lectin blotting with Vero cell-derived and mouse brain-derived Japanese encephalitis vaccines. Vaccine 2011, 29:1859-1862.
47. Verhofstede C., Van Gelder P., Rabaey M. The infection stage-related IgG response to Toxoplasma gondii studied by immunoblotting. Parasitology Research 1988, 74:515-520.
48. Ware P.L., Kasper L.H. Strain Specific antigens of Toxoplasma gondii. American Society for Microbiology 1986, 55:778-783.
49. Warren J., Russ S.B. Cultivation of Toxoplasma in embryonated egg an antigen derived from chorioallantoic membrane. Proceedings of the Society for Experimental Biology and Medicine 1948, 67:85-89.
50. Xue M.F., He S.Y., Zhang J., Cui Y.L., Yao Y., Wang H.X. Comparison of cholera toxin A2/B and murine interleukin-12 as adjuvants of Toxoplasma multiantigenic SAG1-ROP2 DNA vaccine. Experimental Parasitology 2008, 119:352-357.